Depression can be exhausting in ways that are hard to explain to someone who has not lived it. When depression has not improved enough with prior care, you may wonder whether you have treatment-resistant depression.
You may have taken medication consistently, gone to appointments, tried therapy, and made real efforts to sleep, eat, move, and stay connected. Yet you may still feel weighed down by sadness, numbness, hopelessness, or a loss of yourself.
At HavenNexus Advanced Psychiatry & TMS, we help people in Palm Coast, FL make sense of that history without reducing them to a medication list. A thoughtful evaluation can create room for a more individual plan, including a review of our mental health services and the options that may fit your needs.
Treatment-resistant does not mean untreatable
Treatment-resistant depression generally describes depression that has not responded adequately to prior treatment. It is not a judgment about your effort, strength, or willingness to get better. It is a clinical term that helps guide a closer conversation about what has been tried, what got in the way, and what may deserve attention next.
Many clinicians and studies use inadequate response to two appropriately dosed and adequately timed antidepressant trials as a common benchmark. That benchmark is useful, but it is not the whole diagnosis. A full review still matters. One person may have tried several medications with limited benefit. Another may have stopped early because side effects were unbearable. Someone else may have improved partly, then lost progress after a major stressor, medical change, or interruption in care.
The most useful question is often not, “How many things have failed?” It is, “What have we learned from every step so far?” A careful review of diagnosis, earlier treatment adequacy, medical factors, and co-occurring concerns is central to clinical approaches to treatment-resistant depression (Kverno et al., 2021).
How we assess treatment-resistant depression
A depression evaluation should make room for details that can get lost over time. We may ask about your symptom pattern, when it began, and what depression looks like in daily life. We also ask whether there have been periods of elevated mood or a decreased need for sleep.
We may review:
- Medications you have tried, including dose, duration, benefits, and side effects
- Whether you were able to take medication consistently
- Therapy experiences and whether the approach fit your needs
- Sleep, substance use, chronic pain, hormonal changes, and medical conditions
- Trauma history, anxiety, attention concerns, and other symptoms that may affect recovery
- Family psychiatric history and previous hospitalizations
- Current safety, including suicidal thoughts, plans, or behaviors
This review matters because an apparent lack of response can have more than one explanation. A medication may have been stopped before it had enough time to work. Side effects may have limited the dose. Depression may occur alongside another concern that also needs attention. Sometimes the diagnosis itself needs another look.
There is also no single, simple explanation for why depression persists in every person. Neuroimaging studies of treatment resistance (Runia et al., 2022) reflect how varied the biology of treatment-resistant depression can be. That is one reason we do not approach your history as a checklist alone.
Partial improvement still counts
Many people do not feel simply “better” or “not better.” You may be sleeping a little more or have fewer days when getting out of bed feels impossible. At the same time, you may still struggle to work, connect with loved ones, or feel hope.
That partial response is important information. It helps us understand what has helped, even modestly, and what symptoms remain most disruptive. A next-step discussion may include medication changes, another form of treatment, revisiting psychotherapy, or a different level of support.
Augmentation and combination strategies (Nuñez et al., 2022) are among the approaches studied when antidepressant care has not brought adequate relief. The right approach depends on your history, possible side effects, preferences, and overall clinical picture.
Next-step conversations may include more than medication changes
If depression has continued despite prior care, it is reasonable to ask what other evidence-based pathways may be worth discussing. That conversation should include possible benefits, practical requirements, risks, your preferences, and the support available in your life.
For eligible patients with treatment-resistant depression, we may discuss TMS, a noninvasive treatment that uses magnetic pulses to stimulate targeted brain areas. TMS is FDA-cleared for depression. Treatment is typically delivered through a series of outpatient visits. You can learn more about TMS therapy or begin with our TMS self-assessment if you are wondering whether it is a conversation to have.
We may also discuss IV ketamine for treatment-resistant depression when clinically appropriate. Ketamine has psychiatric uses that are off-label, meaning the FDA has not approved ketamine specifically for depression. Its potential role, monitoring needs, medical history considerations, and suitability should be assessed carefully. Our ketamine therapy page offers a starting point for understanding this care.
Another option for eligible adults is SPRAVATO®, the brand name for esketamine nasal spray. For treatment-resistant depression, SPRAVATO® may be used alone or with an oral antidepressant. It is administered in a monitored clinical setting. A recent systematic review of esketamine treatment in adults (Fountoulakis et al., 2025) continues to examine its place in depression care. You can also explore our esketamine treatment options before an appointment.
Some people may need to discuss additional psychiatric interventions, including electroconvulsive therapy. ECT remains an important option in certain situations, especially when depression is severe or urgent. Its role in treatment-resistant depression has been extensively reviewed in ECT research for persistent depression (Hsieh, 2023).
Questions worth bringing to your appointment
You do not need to arrive with a perfect record. Still, it can help to write down what you remember. Consider bringing a list of medications, dates if you know them, side effects, previous clinicians, hospitalizations, and treatments that helped even a little.
You may also ask:
- Do my past treatments appear to have been adequate trials?
- Could another diagnosis, medical issue, or medication be affecting my symptoms?
- What symptoms should we focus on first?
- What treatment options might be appropriate for my history?
- What monitoring, time commitment, and support would each option involve?
Treatment-resistant depression can feel like a closed door. We see it differently. It is a signal to slow down, look closely, and build a plan from the full story instead of repeating the same next step.
If you are ready to talk through that story, you can request an appointment with HavenNexus Advanced Psychiatry & TMS. If you are in immediate danger, have a plan to harm yourself, or cannot stay safe, call or text 988 to reach the 988 Suicide and Crisis Lifeline or call 911.
Works Cited
1. Kverno KS, et al. Treatment-Resistant Depression: Approaches to Treatment. https://pubmed.ncbi.nlm.nih.gov/34459676/
2. Runia N, et al. The neurobiology of treatment-resistant depression: A systematic review of neuroimaging studies. https://pubmed.ncbi.nlm.nih.gov/34890601/
3. Nuñez NA, et al. Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis. https://pubmed.ncbi.nlm.nih.gov/34986373/
4. Fountoulakis KN, et al. Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis. https://pubmed.ncbi.nlm.nih.gov/39876682/
5. Hsieh MH. Electroconvulsive therapy for treatment-resistant depression. https://pubmed.ncbi.nlm.nih.gov/37806717/
6. 988 Suicide and Crisis Lifeline. https://988lifeline.org/
Disclaimer
This article is for educational purposes only and is not a substitute for individualized evaluation, diagnosis, or treatment from a qualified healthcare professional.